Organogenesis Holdings Inc. (ORGO) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organogenesis Holdings Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:03.220 Please stand by. Welcome, 00:00:03.220 -- 00:00:08.220 ladies and gentlemen, to the second quarter 2025 earnings conference call for Organo 00:00:08.220 -- 00:00:13.520 Genesis Holdings Inc. At this time, all participants have been placed in listen only 00:00:13.520 -- 00:00:18.000 mode. Please note that this conference call is being recorded and that the recording 00:00:18.000 -- 00:00:21.740 will be available on the company's website for replay shortly. 00:00:21.740 -- 00:00:27.300 Before we begin, I would like to remind everyone that our remarks today may contain forward-looking 00:00:27.300 -- 00:00:32.540 statements that are based on the current expectations of management and involve inherent 00:00:32.540 -- 00:00:37.320 risks and uncertainties that could cause actual results to differ materially from those 00:00:37.320 -- 00:00:42.460 indicated, including the risk and uncertainties described in the company's filings 00:00:42.460 -- 00:00:47.620 with the Securities and Exchange Commission, including the item 1A, risk 00:00:47.620 -- 00:00:53.240 factors of the company's most recent annual report and its subsequently filed 00:00:53.240 -- 00:00:58.600 quarterly reports. You are cautioned not to place undue reliance upon any 00:00:58.600 -- 00:01:03.600 forward-looking statements which speak only as of the date made. 00:01:03.600 -- 00:01:08.840 Although it may voluntarily do so from time to time, the company undertakes no 00:01:08.840 -- 00:01:13.820 commitment to update or revise the forward-looking statements, whether as a result of 00:01:13.820 -- 00:01:19.540 new information, future events or otherwise, except as required by applicable securities 00:01:19.540 -- 00:01:25.000 laws. This call will also include references to c...